Is the information you provided sourced from a Mayo Clinic study on seronegative autoimmune autonomic ganglionopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

No Mayo Clinic Study on Seronegative Autoimmune Autonomic Ganglionopathy

I am not quoting a Mayo Clinic study on seronegative autoimmune autonomic ganglionopathy. The evidence provided does not contain any Mayo Clinic-specific research on this condition.

What the Evidence Actually Contains

The provided evidence includes:

  • Guidelines on Still's disease and macrophage activation syndrome 1 - completely unrelated to autonomic ganglionopathy
  • Primary immunodeficiency guidelines 2 - addressing different immune disorders
  • Sjögren's syndrome management 3
  • Immune checkpoint inhibitor toxicity guidelines 4
  • Juvenile dermatomyositis recommendations 5
  • Giant cell arteritis/Takayasu arteritis guidelines 6
  • Idiopathic inflammatory myopathies review 7

Relevant Research on Autoimmune Autonomic Ganglionopathy

The only studies addressing autoimmune autonomic ganglionopathy are:

  • A 2009 Mayo Clinic study 8 examining ganglionic acetylcholine receptor autoantibodies in 15,000 patients, but this focused on seropositive cases (antibody-positive), not seronegative disease
  • A 2026 long-term follow-up study 9 specifically examining seropositive AAG patients with documented antibodies
  • A 2022 case report 10 describing a single patient with seronegative AAG presenting with constipation

Key Distinction

The Mayo Clinic research 8 specifically evaluated patients with detectable antibodies (seropositive), finding that 1% of 15,000 tested patients were antibody-positive. This study does not address seronegative autoimmune autonomic ganglionopathy, which by definition lacks detectable ganglionic acetylcholine receptor antibodies.

The seronegative form remains a distinct clinical challenge with limited published evidence and no comprehensive Mayo Clinic study addressing it specifically.

References

2
Guideline

practice parameter for the diagnosis and management of primary immunodeficiency.

Journal of Allergy and Clinical Immunology, 2015

Related Questions

What is the recommended treatment for seronegative autoimmune autonomic ganglionopathy (autoimmune autonomic neuropathy)?
What are the typical symptoms of autoimmune encephalitis?
Can long‑term autonomic autoimmune gangliopathy cause depression, dyslexia, or attention‑deficit/hyperactivity disorder, and is there evidence supporting or refuting this hypothesis?
What is the typical cerebrospinal fluid profile in autoimmune encephalitis?
Is autonomic autoimmune ganglionopathy a permanent condition, and what proportion of patients treated with intravenous immunoglobulin (IVIG) achieve marked improvement or remission?
As the current provider seeing a patient who was prescribed clonazepam five months ago by another clinician, should I refill the medication now, or what assessment steps are required before deciding?
What causes transient erythema and warmth of the ear that resolves within minutes without pain or other symptoms?
What is the appropriate evaluation and management for a 14-year-old boy presenting to urgent care with a one-week history of chest pain?
Which ICD‑10‑CM codes are appropriate for an elderly patient post‑cardiac surgery who has dysphagia requiring thickened liquids, dysarthria, gait instability with walker use, and postoperative status when referring to neurology?
How do I evaluate and manage renal tubular acidosis in a child with growth failure, polyuria, vomiting, dehydration, and chronic non‑anion‑gap metabolic acidosis?
What is the most common clinical finding in hemophagocytic lymphohistiocytosis (HLH) among hypertriglyceridemia, bicytopenia, splenomegaly, and soluble CD25 elevation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.